personalinx Nutraceuticals is developing a line of novel, all-natural nutraceutical products designed to mitigate the negative health effects of air pollution in vulnerable populations, including pregnant women and their unborn babies, young children, and the elderly. The company's first product, pollunex, features a formulation of highly potent antioxidants and anti-inflammatory active ingredients, all derived from natural sources, to enhance the body's pulmonary and cardiovascular immune system. Product development is led by Israeli scientists from the Hebrew University of Jerusalem and the British Columbia University of Vancouver, Canada.